C4 Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.0k | 2.7k | 2.22 |
| 2025-06-30 | $3.9k | 2.7k | 1.43 |
| 2025-03-31 | $143k | 90k | 1.60 |
| 2024-12-31 | $360k | 100k | 3.60 |
| 2024-09-30 | $545k | 96k | 5.70 |
| 2024-06-30 | $419k | 91k | 4.62 |
| 2024-03-31 | $15k | 1.8k | 8.17 |
| 2023-12-31 | $10k | 1.8k | 5.65 |
| 2023-09-30 | $3.3k | 1.8k | 1.86 |
| 2023-06-30 | $11k | 4.0k | 2.75 |
| 2023-03-31 | $211k | 67k | 3.15 |
| 2022-12-31 | $379k | 64k | 5.89 |
| 2022-09-30 | $562k | 64k | 8.78 |
| 2022-06-30 | $453k | 60k | 7.54 |
| 2022-03-31 | $987k | 41k | 24.25 |
| 2021-12-31 | $1.2M | 38k | 32.19 |
| 2021-09-30 | $1.7M | 38k | 44.69 |
| 2021-06-30 | $1.3M | 35k | 37.84 |
| 2021-03-31 | $380k | 10k | 36.96 |
| 2020-12-31 | $285k | 8.6k | 33.17 |